Clinical Trials Sponsored by Protgen Ltd

Total 17260 results

Protein Sciences Corporation

Completed

Safety, Reactogenicity and Immunogenicity of Flublok Quadrivalent (Recombinant Influenza Vaccine,Seasonal Formulation)

Influenza

United States
Protein Sciences Corporation

Completed

Safety and Immunogenicity of PanBlok Influenza Vaccine in Healthy Adults

Influenza

United States
Protein Sciences Corporation

Completed

Safety and Reactogenicity of FluBlok and Comparison of Immunogenicity, Efficacy and Effectiveness Against TIV

Influenza

United States
Prothena Biosciences Limited

Terminated

A Study of PRX004 in Subjects With Amyloid Transthyretin (ATTR) Amyloidosis

Amyloidogenic Transthyretin (ATTR) Amyloidosis

United States, Spain, Sweden, Portugal
Protein Supplies SL

Completed

MR Fat Quantification and Elastography During a Very Low-calorie-ketogenic Diet (Pronokal Method®) vs a Low Calorie Diet

Liver Fat
Protein Sciences Corporation

Completed

Safety and Immunogenicity of PanBlok Influenza Vaccine in Healthy Adults (PSC25)

Influenza

United States
Protein Sciences Corporation

Completed

Immunogenicity and Safety of Trivalent Recombinant Hemagglutinin Influenza Vaccine in Healthy Adults

Influenza

United States
Protein Sciences Corporation

Completed

Comparison of the Immunogenicity, Safety and Reactogenicity of FluBlok, To a Licensed Vaccine In Elderly Adults

Influenza

United States
Protein Supplies SL

Withdrawn

Cost-effectiveness Study of a Multidisciplinary Weight Loss Method to Improve the Health Condition of Obese Patients (PRONOCOST)

Obesity | Obese

Argentina
Protein Supplies SL

Completed

Structural Changes of Subcutaneous Tissue by Ultrasonographies in Patients After Treatment With PnKCelulitis® Program (PnKCelulitis)

Cellulite
Protein Supplies SL

Unknown

Study to Evaluate Effectiveness of a Weight Loss Program in Obese Patients During 3 Months Prior to Bariatric Surgery

Obesity, Morbid | Bariatric Surgery | Comorbidity
Prothena Biosciences Limited

Completed

Multiple Ascending Dose Study of PRX003 in Subjects With Psoriasis

Psoriasis

United States
Protein Sciences Corporation

Completed

Protective Efficacy of Flublok® Quadrivalent Versus Licensed Inactivated Influenza Vaccine in Adults ≥50 Years of Age

Influenza

United States
Prothena Biosciences Limited

Completed

Single Ascending Dose Study of PRX003 in Healthy Subjects

Psoriasis

United States
Protein Sciences Corporation

Completed

Comparison of the Safety of Flublok® Versus Licensed IIV in Healthy, Medically Stable Adults ≥ 50 Years of Age

Influenza

United States
Protein Sciences Corporation

Completed

Immunogenicity and Safety of FluBlok Trivalent Recombinant Hemagglutinin Influenza Vaccine in Healthy Pediatrics

Influenza

United States
Progen Pharmaceuticals
National Cancer Institute (NCI)

Completed

SL-11047 in Treating Patients With Relapsed or Refractory Lymphoma

Lymphoma

United States
Proton Collaborative Group

Recruiting

Hypo-fractionated Radiation Therapy With or Without Androgen Suppression for Intermediate Risk Prostate Cancer

Prostate Cancer

United States
Proton Collaborative Group

Active, not recruiting

Study of Hypo-fractionated Proton Radiation for Low Risk Prostate Cancer

Prostate Cancer

United States
University of Wisconsin, Madison
Progen Pharmaceuticals

Terminated

Study of CGC-11047 in Patients With Metastatic Hormone Refractory Prostate Cancer

Prostate Cancer

United States
Anthony Magliocco

Recruiting

Idylla EGFR Lung Trial

Lung Cancer | Oncology | Technology

United States
Sanofi
Protein Sciences Corporation

Completed

Immunogenicity, Safety, Reactogenicity, Efficacy, Effectiveness and Lot Consistency of FluBlok

Influenza

United States
Tulane University
Ideal Protein

Completed

A Trial of the Ideal Protein System Versus Low Fat Diet for Weight Loss (RENEWAL)

Weight Loss

United States
Proton Collaborative Group

Recruiting

Phase II Protocol of Proton Therapy for Partial Breast Irradiation in Early Stage Breast Cancer

Breast Cancer | Breast Neoplasm | Breast Tumor | Cancer of the Breast

United States
Proton Collaborative Group

Active, not recruiting

A Phase I/II Study of Hypofractionated Proton Therapy for Stage II-III Non-Small Cell Lung Cancer

Lung Neoplasms

United States
Protez Pharmaceuticals, Inc.

Completed

Safety, Potential Efficacy, and Pharmacokinetics of PZ-601 in the Treatment of Complicated Skin and Skin Structure Infection

Skin Infections

United States
Proton Collaborative Group

Recruiting

Conventionally Fractionated vs. Hypofractionated Comprehensive Nodal Irradiation for Breast Cancer Using Pencil Beam Scanning Proton Therapy (COMPRO)

Breast Cancer

United States
Proton Collaborative Group

Recruiting

Registry Study for Radiation Therapy Outcomes

Neoplasms

United States
Proton Collaborative Group

Active, not recruiting

Proton Radiation for Stage II/III Breast Cancer

Breast Cancer | Breast Neoplasm | Breast Tumor | Cancer of the Breast

United States
Proton Collaborative Group

Terminated

External Beam Radiation With or Without Chemotherapy to Treat High Risk Prostate Cancer

Prostate Cancer

United States
EpicentRx, Inc.
Prothex Pharma, Inc.

Completed

Safety and Efficacy of RRx-001 in the Attenuation of Oral Mucositis in Patients Receiving Chemoradiation for the Treatment of Oral Cancers (PREVLAR)

Oral Mucositis

United States
Protein Sciences Corporation
Kaiser Permanente

Completed

Post-Marketing Observational Study of Safety Following Vaccination With Flublok® Compared to Licensed IIV in Adults

Human Influenza

United States
Geriatric Education and Research Institute
Neeuro Pte Ltd; Ministry of Health, Singapore; ProAge Pte Ltd; KKT Technology Pte...

Completed

Evaluation of Pilot Community-based Multi-domain Program Older Adults at Risk of Cognitive Impairment

Cognitive Decline | Cognitive Impairment, Mild

Singapore
Prothena Biosciences Ltd.
Amyloidosis Research Consortium; Amyloidosis Support Groups; Amyloidosis Foundation and other collaborators

Completed

Quality of Life (QOL) Registry for Patients With AL Amyloidosis

AL Amyloidosis | Amyloidosis

United States
Hoffmann-La Roche
Prothena Biosciences Limited

Active, not recruiting

A Study to Evaluate the Efficacy of Prasinezumab (RO7046015/PRX002) in Participants With Early Parkinson's Disease (PASADENA)

Parkinson's Disease

United States, Spain, France, Germany, Austria
The New York Proton Center

Recruiting

Prospective Evaluation of Pencil Beam Scanning Proton Therapy for Previously Irradiated Tumors (ReRT)

Breast Cancer | Head and Neck Cancer | Gynecologic Cancer | Prostate Cancer | Thoracic Cancer | CNS Cancer | GI Cancer

United States
Hoffmann-La Roche
Prothena Biosciences Limited

Active, not recruiting

A Study to Evaluate the Efficacy and Safety of Intravenous Prasinezumab in Participants With Early Parkinson's Disease (PADOVA)

Parkinsons Disease

United States, United Kingdom, Canada, France, Luxembourg, Poland, Spain, Italy, Austria
Prothena Biosciences Limited
Hoffmann-La Roche

Completed

Multiple Ascending Dose Study of PRX002 in Patients With Parkinson's Disease

Parkinson's Disease

United States
Prothena Biosciences Limited
Hoffmann-La Roche

Completed

Single Ascending Dose Study of PRX002 in Healthy Subjects

Parkinson's Disease

United States
The New York Proton Center

Recruiting

Patient-Generated Health Data Collection During Chemoradiotherapy for Lung Cancer (PGHD)

Thoracic Cancer

United States
The New York Proton Center

Recruiting

Phase II Study of Pencil Beam Scanning Proton Stereotactic Body Radiation Therapy for Prostate Cancer

Prostate Cancer

United States
Shanghai Proton and Heavy Ion Center

Recruiting

Prospective Study of Particle Radiotherapy for Breast Cancer With Different Arm Position

Breast Cancer

China
Shanghai Proton and Heavy Ion Center

Recruiting

A Prospective Phase II Study for Adjuvant Hypofractionated Intensity-modulated Proton Radiotherapy for Post Operative Breast Cancer With Implantation Reconstruction

Breast Cancer

China
Shanghai Proton and Heavy Ion Center

Not yet recruiting

Individualized Carbon-Ion Radiotherapy for Patients With Locally Recurrent Nasopharyngeal Carcinoma

Locally Recurrent Nasopharyngeal Carcinoma

China
Shanghai Proton and Heavy Ion Center

Completed

Proton and Carbon Ion Radiotherapy for Locally Advanced Pancreatic Cancer

Pancreatic Carcinoma

China
Shanghai Proton and Heavy Ion Center

Terminated

Trial Evaluating Carbon Ion Radiotherapy With Concurrent Chemotherapy for Locally Recurrent Nasopharyngeal Carcinoma

Nasopharyngeal Carcinoma

China
Shanghai Proton and Heavy Ion Center

Unknown

Trail Evaluating Particle Therapy With or Without Apatinib for H&N Adenoid Cystic Carcinoma

Adenoid Cystic Carcinoma

China
Wageningen University and Research
The Protein Brewery

Completed

Digestibility of Fermotein™ (MyDi)

Digestive System

Netherlands
Proteon Therapeutics
University of California, San Francisco

Completed

Pilot Study of PRT-201 Following Angioplasty in Patients With Peripheral Artery Disease (PAD)

Peripheral Artery Disease

United States
Wageningen University and Research
The Protein Brewery

Completed

Tolerance of Regular Meal Intake With Mycoprotein (TOMMY)

Gastrointestinal Complication

Netherlands

3

Subscribe